Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Australian Pharmaceutical Industries Provides HY 2021 Results Presentation

22 Apr 2021  |  09:19:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: API HY21 Results Presentation

Australian Pharmaceutical Industries provided HY 2021 results presentation. It reported revenue is resilient in the face of COVID down 2.6% on the pcp. The Underlying EBITDA is down 11.8% and Underlying EBIT is down 26.5% on the pcp reflecting lockdown restrictions and low foot traffic in CBD stores. It declared dividend of 1.5c for H1 2021, representing a payout of 47% of NPAT.

Please click here for full details

See more ASX300 News Announcements